首页|益糖康抑制坏死性凋亡及EMT减轻糖尿病肾病肾损伤的实验研究

益糖康抑制坏死性凋亡及EMT减轻糖尿病肾病肾损伤的实验研究

扫码查看
目的 探究益糖康对糖尿病肾病肾损伤的影响,并研究其对上皮-间质转化和坏死性凋亡相关途径的作用及机制。方法 细胞分为NG组、HG组、HG+NEC-1组、HG+YTK组、HG+DAPA组。动物分为正常对照组、模型组、阳性对照组、益糖康(YTK)高、中、低剂量组。通过CCK-8、流式细胞术检测细胞增殖活力以及凋亡水平;通过HE、Masson染色以及透射电镜观察肾组织的形态和超微结构;通过Western blot检测细胞及肾组织中坏死性凋亡以及EMT相关蛋白的表达。结果 经益糖康治疗后,HK-2细胞增殖活力增强,凋亡率降低(P<0。05)。在体内外实验中,坏死性凋亡以及EMT相关蛋白RIP1、RIP3、MLKL、Vimentin、α-SMA水平下降,E-cadherin水平升高(P<0。05)。结论 YTK能够减轻糖尿病肾病引起的肾损伤,其作用机制可能与抑制坏死性凋亡和EMT的发生有关。
Experimental study on the inhibition of Necroptosis and Epithelial-Mesenchymal Transi-tion by Yitangkang to Mitigate Diabetic Nephropathy-Induced Renal Injury
Objective This study aims to explore the effects of Yitangkang(YTK)onkidney injury indiabetic nephropathy.It further investigates the role and mechanism of YTK in epithelial-mesenchymal transition(EMT)and necroptosis-related path-ways.Methods HK-2 cells were divided into five groups:NG(normal glucose),HG(high glucose),HG+NEC-1,HG+YTK,and HG+DAPA.Animal subjects were categorized into normal control,model,positive control,and YTK high,medium,and low dose groups.Cell proliferation viability and apoptosis levels were measured using CCK-8 assay and flow cytometry,re-spectively.Renal tissue morphology and ultrastructure were observed through HE and Masson staining,and transmission electron microscopy.The expression of necroptosis and EMT-related proteins in cells and renal tissues was detected by Western blot.Re-sults After treatment with YTK,proliferation viability of HK-2 cells enhanced,and apoptosis rates were reduced(P<0.05).Levels of necroptosis and EMT-related proteins,including RIP1,RIP3,MLKL,Vimentin,α-SMA,decreased,while E-cadherin levels increased in vitro and vivo level(P<0.05).Conclusion YTK can alleviate kidney damage caused by diabetic ne-phropathy.Its mechanism may be related to the inhibition of necroptosis and the occurrence of EMT.

Diabetic nephropathyYitangkangNecroptosisEMTRenal injury

孟桐宇、杨宇峰、任艳玲、石岩

展开 >

辽宁中医药大学,辽宁沈阳 110847

糖尿病肾病 益糖康 坏死性凋亡 上皮-间质转化 肾损伤

2024

时珍国医国药
时珍国医国药杂志社

时珍国医国药

北大核心
影响因子:0.887
ISSN:1008-0805
年,卷(期):2024.35(9)